GERMANY - KfW joins other VCs in backing Protagen AG
Kreditanstalt für Wiederaufbau (KfW) has joined existing lead investors MIG AG and Co KG Beteiligungsfonds 3 and S-Venture Capital Dortmund GmbH in raising EUR 1m in interim financing for protein research company Protagen AG. This is the third round of funding for the company. Protagen is a provider of products, services and software solutions for protein research. Recently, Protagen has received a BioChance Plus grant from the German government to identify biomarkers for multiple sclerosis and rheumatoid arthritis. The company is headquartered in Dortmund, and has a second office in New Jersey, US. At present, it employs a staff of 25.
More on Early-stage
Gorillas raises circa USD 1bn in Delivery Hero-led Series C
New funding comes just seven months after a Series B, with the company doubling in value
French mega-rounds shoot up in 2021
France has already seen as many rounds of EUR 100m and above than in 2019 and 2020 combined, Unquote Data shows
L Catterton et al. in EUR 100m round for SellerX
SellerX has already raised amost EUR 250m in debt and equity in its 12 months since inception
Mega-rounds fuel record H1 for venture and growth
Largest rounds inked in the first six months of 2021 read like a veritable Who's Who of European fintech heavyweights
Latest News
Verdane scores 5x MOIC in partial exit of Inriver to THL
Majority investment from THL Partners sees Verdane retain a minority stake in the Swedish company
CVC to buy sports nutrition specialist The Quality Group
GP to acquire majority stake via Fund VIII; German group’s founders to reinvest in the deal
DBAG to target EUR 1.3bn-EUR 1.5bn for new buyout fund next year
German GP’s new vehicle will be slightly larger than its predecessor, which is set to complete deployment in two years
Alcedo heads for June final close for Fund V
Italian GP has received EUR 230m in commitments to date for Fund V against a EUR 250m hard-cap